BR96-doxorubicin immunoconjugate(redirected from Bms-182248-01)
BR96-doxorubicin immunoconjugateAn antibody-drug conjugate composed of the chimeric monoclonal antibody BR96, chemically linked to the cytotoxic drug doxorubicin. The antibody moiety of BMS-182248-1 binds to Lewis Y, a cell surface antigen expressed on many solid tumour cells where it intercalates with DNA, inhibiting DNA replication and repair, RNA synthesis and protein synthesis. BR96-doxorubicin immunoconjugate is now known as SGN-15.
Segen's Medical Dictionary. © 2012 Farlex, Inc. All rights reserved.